New pelvic inflammatory disease therapy research from Whittall Street Clinic discussed

Researchers detail in "Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial," new data in pelvic inflammatory disease. According to recent research from Birmingham, the United Kingdom, "This multinational, multicentre, prospective, randomised, double blind, parallel group, non-inferiority study compared the efficacy and safety of moxifloxacin monotherapy with ofloxacin plus metronidazole in women with uncomplicated pelvic inflammatory disease. Women from hospitals throughout 13 countries received a 14 day course of either oral moxifloxacin, 400 mg once daily (n=384), or oral ofloxacin, 400 mg...

Want to see the full article?

• Purchase this article for only $3.00